Stay updated on M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial

Sign up to get notified when there's something new on the M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.5.0 was added and revision v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-19T08:36:39.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3 in the history. No substantive content changes are evident from the screenshots.
    Difference
    0.1%
    Check dated 2026-03-12T02:49:59.000Z thumbnail image
  4. Check
    28 days ago
    No Change Detected
  5. Check
    49 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the history; older notices (v3.4.1 and a government funding banner) were removed. These updates affect the UI/site banners rather than the clinical trial content.
    Difference
    0.5%
    Check dated 2026-02-11T12:00:37.000Z thumbnail image
  6. Check
    57 days ago
    Change Detected
    Summary
    A system-wide funding notice was added to the page and the revision version updated from v3.4.0 to v3.4.1.
    Difference
    0.5%
    Check dated 2026-02-04T06:32:20.000Z thumbnail image
  7. Check
    64 days ago
    Change Detected
    Summary
    The history page UI now includes a glossary toggle, color-coded highlights for additions and deletions, and updated revision/version information. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-01-28T03:53:53.000Z thumbnail image
  8. Check
    78 days ago
    Change Detected
    Summary
    The Record History now includes a new revision entry v3.3.4; the entry for v3.3.3 has been removed.
    Difference
    0.1%
    Check dated 2026-01-14T02:00:42.000Z thumbnail image

Stay in the know with updates to M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the M7824 Versus Pembrolizumab in 1L PD-L1+ NSCLC Clinical Trial page.